Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02363270 · ClinicalTrials.gov registry record · NA

Ketamine: Comparison of IV Push vs. IV Drip

A NA study of Pain, sponsored by Antonios Likourezos.

Completed
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT02363270: Completed NA study of Pain, sponsored by Antonios Likourezos.

NCT02363270 is a NA study of Pain that has completed, run by Antonios Likourezos. The registered enrollment target is 48 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02363270, a NA study of Pain, has completed, sponsored by Antonios Likourezos.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

Our previous published research comparing the efficacy of intravenous ketamine to morphine has shown ketamine to provide equivalent relief of moderate to severe acute pain in emergency medicine patients. Secondary analysis of the previous published research has also revealed ketamine to have statistically more side effects. The investigators believe that increasing the time of administration of the ketamine, from a push injection to a drip infusion, will minimize the side effects experienced by recipients of ketamine.

Primary Outcome

Overall rate of feeling of unreality as measured by Side Effects Rating Scale for Dissociative Anesthetics (SERSDA)

Conditions Studied

Interventions

  • PROCEDURE Ketamine

Study Locations (1)

New York

  • Maimonides Medical Center - Brooklyn

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2015-04-01
Est. Completion 2017-02-28
Phase NA
Antonios Likourezos

33 total trials

What the finished NCT02363270 record still lists

NCT02363270 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Ketamine is the first listed.

NCT02363270 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02363270 about?

NCT02363270 is a clinical study titled "Ketamine: Comparison of IV Push vs. IV Drip". Our previous published research comparing the efficacy of intravenous ketamine to morphine has shown ketamine to provide equivalent relief of moderate to severe acute pain in emergency medicine patients. Secondary analysis of the previous published research has also revealed ketamine to have statist...

What is the current status of trial NCT02363270?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2015-04-01. Estimated completion is 2017-02-28.

What conditions does trial NCT02363270 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT02363270?

The interventions under investigation include: Ketamine (PROCEDURE).

Who is sponsoring clinical trial NCT02363270?

This trial is sponsored by Antonios Likourezos, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02363270 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02363270's enrollment target sits among peer trials

48 265th of 374 higher than 109 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02363270, the US trial registry maintained by the National Library of Medicine. NCT02363270 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.